MDNA vs. ITH, FRX, CRDL, IPA, APM, GXE, GPH, WMD, EQ, and SGW
Should you be buying Medicenna Therapeutics stock or one of its competitors? The main competitors of Medicenna Therapeutics include International Tower Hill Mines (ITH), Fennec Pharmaceuticals (FRX), Cardiol Therapeutics (CRDL), ImmunoPrecise Antibodies (IPA), Andean Precious Metals (APM), Gear Energy (GXE), Graphite One (GPH), WeedMD (WMD), EQ (EQ), and Shoal Games (SGW). These companies are all part of the "pharmaceutical products" industry.
Medicenna Therapeutics vs. Its Competitors
International Tower Hill Mines (TSE:ITH) and Medicenna Therapeutics (TSE:MDNA) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.
In the previous week, International Tower Hill Mines and International Tower Hill Mines both had 1 articles in the media. International Tower Hill Mines' average media sentiment score of 0.20 beat Medicenna Therapeutics' score of 0.00 indicating that International Tower Hill Mines is being referred to more favorably in the media.
International Tower Hill Mines has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Comparatively, Medicenna Therapeutics has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500.
International Tower Hill Mines has higher earnings, but lower revenue than Medicenna Therapeutics. International Tower Hill Mines is trading at a lower price-to-earnings ratio than Medicenna Therapeutics, indicating that it is currently the more affordable of the two stocks.
International Tower Hill Mines has a net margin of 0.00% compared to Medicenna Therapeutics' net margin of -533,640.00%. International Tower Hill Mines' return on equity of -5.82% beat Medicenna Therapeutics' return on equity.
71.8% of International Tower Hill Mines shares are held by institutional investors. Comparatively, 13.0% of Medicenna Therapeutics shares are held by institutional investors. 0.5% of International Tower Hill Mines shares are held by insiders. Comparatively, 22.6% of Medicenna Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
International Tower Hill Mines beats Medicenna Therapeutics on 7 of the 11 factors compared between the two stocks.
Get Medicenna Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDNA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MDNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Medicenna Therapeutics Competitors List
Related Companies and Tools
This page (TSE:MDNA) was last updated on 8/10/2025 by MarketBeat.com Staff
